文献速递急性肾损伤

脂质体泼尼松龙局部递送在大鼠肾缺血再灌注损伤中诱导抗炎表型

Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

研究在大鼠肾缺血再灌注损伤模型中评估脂质体包裹泼尼松龙的局部递送能力及其对巨噬细胞的影响。体外实验显示巨噬细胞摄取脂质体,泼尼松龙和脂质体泼尼松龙均减少IL-6产生并激活糖皮质激素受体。体内实验表明荧光脂质体在炎症肾脏积聚,脂质体泼尼松龙增加ED2阳性抗炎巨噬细胞,并减少MCP-1 mRNA产生。结论提示脂质体包裹是向炎症肾脏局部递送糖皮质激素的有前景策略。

要点

  • 脂质体可在肾缺血再灌注损伤炎症部位局部积聚。
  • 脂质体泼尼松龙促进抗炎巨噬细胞表型并减少MCP-1表达。
  • 脂质体包裹策略可能减少全身高剂量糖皮质激素副作用。

核心结论

  • 脂质体包裹是向炎症肾脏局部递送糖皮质激素的有前景策略。

研究设计与样本

  • 体外用人巨噬细胞与荧光脂质体、脂质体泼尼松龙、泼尼松龙、空脂质体或生理盐水孵育。
  • 体内对大鼠进行缺血再灌注损伤后静脉注射上述制剂,评估摄取和治疗效果。

主要发现

  • 体外巨噬细胞在8小时后内化脂质体。
  • 泼尼松龙或脂质体泼尼松龙减少IL-6产生,均诱导糖皮质激素受体核转位和PER1 mRNA上调。
  • 体内荧光脂质体在炎症肾脏积聚。
  • 脂质体泼尼松龙增加ED2阳性抗炎巨噬细胞。
  • 泼尼松龙和脂质体泼尼松龙均减少MCP-1 mRNA产生。

临床怎么用

  • 该策略尚处于动物实验阶段,暂未提供临床用药方案。

局限性

  • 研究仅在大鼠模型和体外巨噬细胞中进行,尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of inflammatory kidney diseases with systemic high-dose glucocorticoids (GCs) has severe side effects. Liposomal encapsulation could facilitate local delivery of GCs to the inflamed kidney, as liposomes encapsulate their payload until extravasation at sites of inflammation, potentially resulting in local bioactivity. Our aim was to evaluate the ability of liposomes to accumulate locally after renal ischaemia-reperfusion injury in the rat and to study its effect on macrophages. METHODS: In vitro, human macrophages were incubated with fluorescent liposomes, liposomal prednisolone, prednisolone, empty liposomes or saline. Uptake was studied microscopically and treatment effect was assessed by interkeukin 6 (IL-6) enzyme-linked immunosorbent assay. The mechanism of action was evaluated by analysing GC receptor activation by microscopy and quantitative polymerase chain reaction (qPCR). In vivo, rats were subjected to ischaemia-reperfusion injury and were injected intravenously with fluorescent liposomes, liposomal prednisolone, prednisolone, empty liposomes or saline. Uptake was measured by the FLARE camera and the treatment effect by immunohistochemistry for myeloid cells and qPCR for inflammatory markers. RESULTS: In vitro, macrophages internalized liposomes after 8 hours. Prednisolone or liposomal prednisolone treatment reduced IL-6 production and both compounds induced translocation of the GC receptor to the nucleus and upregulation of PER1 messenger RNA (mRNA), indicating a similar mechanism of action. In vivo, fluorescent liposomes accumulated in the inflamed kidney. Liposomal prednisolone treatment increased the presence of ED2-positive anti-inflammatory macrophages and both prednisolone and liposomal prednisolone reduced monocyte chemoattractant protein-1 (MCP-1) mRNA production, indicating a reduced pro-inflammatory profile in the kidney. CONCLUSIONS: Liposomal encapsulation is a promising strategy for local delivery of glucocorticoids to the inflamed kidney.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. van Alem CMA, Boonstra M, Prins J, et al. Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat. Nephrol Dial Transplant. 2018. PMID: 28992069. doi:10.1093/ndt/gfx204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。